Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 364.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -82.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4,395.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -538.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9,850.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,292.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -146.00 |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 126,951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126,951.00 |
| Dec 31, 2025 | 133,601.00 |
| Sep 30, 2025 | 141,499.00 |
| Jun 30, 2025 | 136,917.00 |
| Mar 31, 2025 | 287,396.00 |
| Dec 31, 2024 | -84,487.00 |
| Sep 30, 2024 | -84,302.00 |
| Jun 30, 2024 | -144,245.00 |
| Mar 31, 2024 | -341,364.00 |
| Dec 31, 2023 | -35,344.00 |
| Sep 30, 2023 | -23,566.00 |
| Jun 30, 2023 | -74,171.00 |
| Mar 31, 2023 | -23,688.00 |
| Dec 31, 2022 | 23,777.00 |
| Sep 30, 2022 | -17,996.00 |
| Jun 30, 2022 | -13,044.00 |
| Mar 31, 2022 | 7,359.00 |
| Dec 31, 2021 | 181,529.00 |